Frontlight ResearchEarly access
Aortic stenosis trials in South Korea
3 of 6 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Not yet taking people in South KoreaAngiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
- Where
- Seoul
- Age
- 40 years and over
- People
- 632
- Run by
- Seoul National University Hospital
See details and how to joinNCT07735130 - No phaseTaking peopleAspirin vs Clopidogrel After TAVR
- Where
- Seoul
- Age
- 19 years and over
- People
- 270
- Run by
- Yonsei University
See details and how to joinNCT05493657 - Phase 4Taking peopleENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
- Where
- Bucheon-si, Changwon, Daegu, Daejeon, Gangneung, Gwangju, Ilsan, Incheon, Pusan, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Ulsan
- Age
- 19 years and over
- People
- 1,040
- Run by
- Duk-Woo Park, MD
See details and how to joinNCT05672836